| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e4254d9d06a1c40b7571f1486dcd39b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e626e9140302061ed48d4047da11cec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ac126636f3e5d9872711e079ecada0e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 |
| filingDate |
1997-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bf0b5a2f898374683d27e7693f3794b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7ab0017a0339e2c55da092f292684d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3e85fadd82e8a07edf5ac7f37282528 |
| publicationDate |
2002-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0998279-B1 |
| titleOfInvention |
Pharmaceutical injection solution containing taxol |
| abstract |
The present invention is a pharmaceutical composition containing TAXOL which is used as an injection solution effective in clinical utilization as a cancer-inhibiting drug. The addition of calcium disodium edetate and tromethamine to conventional injection solutions enhances the stability of the solution and reduces the side effects normally associated with administration of TAXOL. The composition comprises dehydrated ethanol, polyethoxylated castor oil, tromethamine and calcium disodium edetate in specified ranges. |
| priorityDate |
1997-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |